share_log

DA Davidson Maintains Neutral on Usana Health Sciences, Lowers Price Target to $57

DA Davidson Maintains Neutral on Usana Health Sciences, Lowers Price Target to $57

DA Davidson對Usana Health Sciences保持中立,將目標股價下調至57美元
Benzinga Real-time News ·  2022/07/28 06:24

DA Davidson analyst Linda Bolton Weiser maintains Usana Health Sciences (NYSE:USNA) with a Neutral and lowers the price target from $58 to $57.

DA Davidson分析師琳達·博爾頓·韋瑟維持Usana Health Sciences(紐約證券交易所代碼:USNA)的中性評級,並將目標股價從58美元下調至57美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論